Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease (Q84398372)
Jump to navigation
Jump to search
scientific article published on 21 June 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease |
scientific article published on 21 June 2011 |
Statements
Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease (English)
Karthik Ramasamy
Beth Hazel
Shameem Mahmood
Sophie Corderoy
Stephen Schey